Altimmune

(NASDAQ) ALT

Current Price$2.91

Market Cap$585.37M

Since IPO (2017)-99%

5 Year-77%

1 Year-45%

1 Month+7%

Altimmune Financials at a Glance

Market Cap

$585.37M

Revenue (TTM)

$36.00K

Net Income (TTM)

-$91.08M

EPS (TTM)

-$0.94

P/E Ratio

-3.21

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$2.91

Volume

3,144,481.81

Open

$2.99

Price

$2.91

Volume

3,144,481.81

Open

$2.99

Previous Close

$2.90

Daily Range

$2.90 - $3.00

52-Week Range

$2.56 - $7.73

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$2.91

Volume

3,144,481.81

Open

$2.99

Previous Close

$2.90

Daily Range

$2.90 - $3.00

52-Week Range

$2.56 - $7.73

ALT News

Patient being weighed by a medical professional

If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

Alex CarchidiJun 29, 2024

Pharmacist handing prescription medication to a customer.

Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential

David Jagielski, CPAApr 20, 2024

Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.

Adam SpataccoApr 9, 2024

Page 1

ALT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Altimmune

Industry

Biotechnology

Sector

Health Care

Employees

Headquarters

Gaithersburg, MD 20878, US

ALT Financials

Key Financial Metrics (TTM)

Gross Margin

-415%

Operating Margin

-2692%

Net Income Margin

-2530%

Return on Equity

-43%

Return on Capital

-30%

Return on Assets

-27%

Earnings Yield

-31.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$585.37M

Shares Outstanding

194.47M

Volume

3.14M

Avg. Volume

3.92M

Financials (TTM)

Gross Profit

$41.00K

Operating Income

-$94.49M

EBITDA

-$87.03M

Operating Cash Flow

-$67.54M

Capital Expenditure

-$11.00K

Free Cash Flow

-$67.55M

Cash & ST Invst.

$273.46M

Total Debt

$35.69M

Altimmune Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$23.00K

-560.0%

Gross Margin

0.00%

N/A

Market Cap

$585.37M

N/A

Market Cap/Employee

$9.92M

N/A

Employees

N/A

Net Income

-$22.56M

-15.3%

EBITDA

-$24.22M

-19.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$295.69M

+99.5%

Accounts Receivable

$1.67M

-32.4%

Inventory

$0.00

N/A

Long Term Debt

$35.58M

+2551.4%

Short Term Debt

$265.00K

+8.2%

Return on Assets

-27.14%

N/A

Return on Invested Capital

-29.88%

N/A

Free Cash Flow

-$20.96M

-24.5%

Operating Cash Flow

-$20.94M

-24.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.26-5.73%

ANROAlto Neuroscience, Inc.

ANROAlto Neuroscience, Inc.$18.71-5.51%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$6.90-4.03%

DBVTDBV Technologies S.A.

DBVTDBV Technologies S.A.$18.23-3.03%

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$27.02-3.60%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.47+0.77%

LRMRLarimar Therapeutics, Inc.

LRMRLarimar Therapeutics, Inc.$3.30-5.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$56.15+0.19%

NOKNokia

NOKNokia$16.85+0.04%

ONDSOndas

ONDSOndas$13.58+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.74-0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$38.05-0.06%

FFord Motor Company

FFord Motor Company$16.15-0.03%

SMRNuScale Power

SMRNuScale Power$13.95+0.08%

Questions About ALT

What is the current price of Altimmune?

Altimmune is trading at $2.90 per share.

What is the 52-week range for Altimmune?

Over the past 52 weeks, Altimmune has traded between $2.56 and $7.73.

How much debt does Altimmune have?

As of the most recent reporting period, Altimmune reported total debt of $35.85M.

How much cash does Altimmune have on hand?

Altimmune reported $97.64M in cash and cash equivalents in its most recent financial results.

What is Altimmune’s dividend yield?

Altimmune does not currently have a dividend yield.

Altimmune

Altimmune Financials at a Glance

ALT News

Why Altimmune Was Such a Robustly Healthy Stock on Thursday

Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year

Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential

Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.

ALT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Altimmune

ALT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Altimmune Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALT

What is the current price of Altimmune?

What is the 52-week range for Altimmune?

How much debt does Altimmune have?

How much cash does Altimmune have on hand?

What is Altimmune’s dividend yield?

Premium Investing Services